Bio-Rad Laboratories | BIO - Sales Revenues

Stock Price
289.12
Daily Change
1.28 0.44%
Monthly
6.94%
Yearly
20.17%
Q2 Forecast
281.68

Bio-Rad Laboratories reported $693.2M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Agilent USD 1.8B 63M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Bio Techne USD 295.9M 9.34M Dec/2025
Bio-Rad Laboratories USD 693.2M 40.2M Dec/2025
Bruker USD 977.2M 116.7M Dec/2025
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Danaher USD 5.95B 890M Mar/2026
General Electric Aerospace USD 11.6B 270M Mar/2026
Illumina USD 1.16B 80M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Laboratory Of America USD 3.52B 40M Dec/2025
Merck USD 16.4B 880M Dec/2025
Mettler Toledo International USD 1.13B 100M Dec/2025
Myriad Genetics USD 209.8M 4.1M Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Quest Diagnostics USD 2.9B 90M Mar/2026
Repligen USD 197.91M 8.91M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Siemens EUR 19.14B 2.29B Dec/2025
Standard Biotools USD 23.8M 4.24M Dec/2025
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Tosoh JPY 256.94B 2.93B Dec/2025
Waters USD 932M 132M Dec/2025